Predicting Biotech Breakouts Before They Happen
🚀 Recent ScanScor Breakout Wins
Predicted in advance. No hype. No guesswork. Just AI-powered precision — 15 confirmed breakouts from our first 130 predictions (July 2025).
ScanScor launched in July 2025, and full access is still FREE!
Many prediction windows remain open — and others haven’t yet begun. The next breakout could be tomorrow. Join us as we prove the power of AI predictions resulting from thorough screening and carefully crafted prompts.
These results established ScanScor.com
Become a MemberScanScor enters its next phase in 2026
With over 20 biotech breakouts successfully predicted, the ScanScor platform is rapidly gaining traction among traders seeking early, data-driven insight.
To ensure reliability at scale, we intentionally deferred the launch of Advanced Reports & Scoring while rolling out critical core enhancements that now define ScanScor’s edge:
✅ Breaking News Alerts (Email & Telegram)
Instant notification when meaningful news breaks on tickers with active predictions.
✅ AI-Confirmed Catalyst Alerts (Email & Telegram)
Upon breaking news, alerts are sent only when AI determines the market is likely to react, filtering noise and prioritizing signal.
✅ NDAPR — News-Driven AI Prediction Revision
NDAPR enables ScanScor’s AI to dynamically reevaluate and revise predictions as new information arrives — refining outlooks, adjusting time windows, and adapting in real time as events unfold.
Together, these capabilities are designed to generate a higher-confidence alpha signal, all in pursuit of ever-greater prediction accuracy.
FREE seats at ScanScor are available for a limited time — 383 members and growing.
The ScanScor Prediction Strategy
Step 1 — Detect Catalysts Early
Our Biomed Prediction Engine scans financials, clinical trial data, and news to uncover biotech companies preparing for breakthrough events. These are the moments when stocks often surge.
Step 2 — Define the Investment Window
Each prediction includes a clear time window and target range. This helps you know when a breakout is most likely — and how high it could go.
Step 3 — Track Results and Refine
We publish every prediction and score it after the fact. That way, you can see what worked, what didn’t, and how the system keeps getting sharper over time.
Following the ScanScor strategy is easy as 1, 2, 3
1
Review AI predictions of top biotech candidates.
2
Compare ROI, time windows, and price targets.
3
Use AI summaries, charts, and commentary to act confidently — early.
On July 1st, 2025, we screened 640 biotech companies for signals that often come before major price movement. Ranking was our first step, narrowing 640 companies to the most promising ~20% (124).
Each flag represents a measurable change in fundamentals that may indicate an emerging catalyst. Companies are ranked by how many of these indicators they’ve triggered. This process allows us to focus on the most obviously promising candidates for deeper analysis and prediction. Original predictions were immediately published in advance and remain publicly visible at archive.org
21,639
High R&D to Revenue Ratio14,302
Cash Runway Risk4,255
Revenue Growth Acceleration3,685
Revenue Spike ≥20%1,349
Net Income Breakout20
Upcoming Clinical Trial (Phase 2)13
Upcoming Clinical Trial (Phase 3)0
New Predictions Today
0
New Predictions This Month
136
Total Predictions
Visit regularly to view Orbo’s successful forecasts. Get a FREE ScanScor User Account to have full access to early notice of high-potential breakout candidates with approaching catalyst windows.
Recent Comments